GlucoSentient Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.85M
Latest Deal Amount
  • Investors
  • 7

GlucoSentient General Information


Developer of personal glucose meters designed to detect drug molecules, contaminants and adulterants. The company's meters assists to quantitatively and conveniently detect non-glucose targets, enabling health care providers to take immediate medical decisions without any delay.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Primary Office
  • 2100 South Oak Street
  • Suite 101
  • Champaign, IL 61820
  • United States
+1 (217) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

GlucoSentient Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2018 $1.85M 00000 Completed Generating Revenue
6. Grant 04-Jan-2017 00000 00000 Completed Generating Revenue
5. Grant 16-Sep-2013 00000 00000 Completed Generating Revenue
4. Early Stage VC 12-Oct-2012 00000 00000 Completed Generating Revenue
3. Grant 01-Jun-2012 00000 Completed Generating Revenue
2. Grant 11-Apr-2012 $10K Completed Generating Revenue
1. Accelerator/Incubator 14-Dec-2011 Completed Generating Revenue
To view GlucoSentient’s complete valuation and funding history, request access »

GlucoSentient Executive Team (5)

Name Title Board Seat Contact Info
Tian Lan Ph.D Co-Founder & Chief Technology Officer
Yi Lu Co-Founder & Scientific Advisor
Steven Mayer MD Chief Medical Officer
You’re viewing 3 of 5 executive team members. Get the full list »

GlucoSentient Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

GlucoSentient Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Illinois Ventures Venture Capital Minority 000 0000 000000 0
Serra Ventures Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »